An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...

A new multi-centre study, funded by ICMR & published in The Lancet, flags Nontuberculous Mycobacterial disease as an emerging ...

Tuberculosis (TB) bacteria appear in red inside a lung granuloma from a mouse infected with Mycbacterium tuberculosis, the bacterium that causes TB. A new genetic study of the bacterium in mice sheds ...

Tuberculosis (TB) is one of the world's most common infectious diseases. Although infection with the Mycobacterium tuberculosis bacterium primarily affects the lungs, up to 25% of all infected people ...

Tuberculosis cases are still widespread in India, while lung cancer cases are steadily rising. To make matters more challenging, the two conditions often present with similar symptoms, leading to ...

More than 8 million people were diagnosed with tuberculosis last year, the World Health Organization said Tuesday, the highest number recorded since the U.N. health agency began keeping track. About 1 ...

A single Mycobacterium tuberculosis bacterium is small enough to ride an exhaled droplet all the way down into the deepest pocket of the lung, where a single layer of alveolar cells is all that ...

LONDON, April 25 (Reuters) - Scientists have identified a key enzyme responsible for destroying lung tissue in tuberculosis (TB) and say the finding could lead swiftly to new treatments for the highly ...

The Georgia lawyer whose travel to attend his wedding in Greece set off international health alarms because he has a difficult-to-treat form of tuberculosis was released Thursday from the Denver, ...